Di Bella D, Catalano M, Cichon S, Nöthen M M
IRCCS H San Raffaele, DSNP, Milan, Italy.
Psychiatr Genet. 1996 Fall;6(3):119-21. doi: 10.1097/00041444-199623000-00003.
Although serotonergic dysregulation is a leading pathogenetic hypothesis for obsessive-compulsive disorder (OCD), some evidence also suggests a possible dysregulation of the dopaminergic system in this disorder. Therefore, individual differences in deoxyribonucleic acid (DNA) coding for dopamine receptor proteins might contribute to the genetic background of this disorder. Previously we reported a null mutation in exon 1 of the dopamine D4 receptor gene. The variant type is characterized by a 13 bp deletion and is predicted to code for a truncated, non-functional receptor. We assessed the frequency of this polymorphism in 157 OCD patients, 196 schizophrenics, 111 bipolars and 162 healthy controls of Italian descent. Our findings do not implicate a role for this mutation in conferring a susceptibility to OCD and confirm previous negative results regarding its involvement in schizophrenia and bipolar disorder.
尽管血清素调节异常是强迫症(OCD)的主要发病机制假说,但一些证据也表明该疾病中多巴胺能系统可能存在调节异常。因此,多巴胺受体蛋白的脱氧核糖核酸(DNA)编码中的个体差异可能导致该疾病的遗传背景。此前我们报道了多巴胺D4受体基因外显子1中的一个无效突变。该变异类型的特征是13个碱基对的缺失,预计编码一个截短的、无功能的受体。我们评估了157名强迫症患者、196名精神分裂症患者、111名双相情感障碍患者以及162名意大利裔健康对照者中这种多态性的频率。我们的研究结果并未表明该突变在赋予强迫症易感性方面起作用,并证实了之前关于其与精神分裂症和双相情感障碍无关的阴性结果。